Europe Cell Therapy Bioprocessing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Bioreactor, Lyophilization, Electrospinning, Control flow Centrifugation, Ultrasonic Lysis, Genome Editing Technology, Cell Immortalization Technology, and Viral Vector Technology); Cell Type (Stem Cell, Immune Cell, Human Embryonic Stem Cell, Pluripotent Stem Cell, and Hematopoietic Stem Cells), Indication (Cardiovascular Disease (CVD), Oncology, Wound Healing, Orthopaedic, and Others); End User (Hospitals and Clinics, Diagnostic Centres, Regenerative Medicine Centres, and Academic and Research Institute)

TIPRE00024508 | Pages: 183 | Biotechnology | Aug 2021 | Type: Regional | Status: Published

Market Introduction

Cell therapy bioprocessing is a subfield of bioprocess engineering that bridges cell therapy and bioprocessing (i.e., biopharmaceutical manufacturing). Cell therapy is one of the fastest-growing areas of the life sciences. It entails delivering entire living cells to a patient to treat disease.

Thus, the growing approvals for cell therapies is expected to create a significant demand for cell therapy bioprocessing in the coming years, which is further anticipated to drive the cell therapy bioprocessing market.

As expected, many companies, including hardware and service providers, are increasing their pandemic-related R&D and manufacturing. Suppliers are bracing for increased business as companies and governments rush to develop, test, and deploy pandemic-related vaccines, therapeutics, and diagnostics. There has also been a demand for increased short-term supply stockpiling. However, in long run the demand for the cell therapy bioprocessing is expected to increase owing to supportive government initiatives. For instance, UK government has allotted 100 million Euros funds to the Cell and Gene Therapy Catapult Manufacturing Innovation Centre to expedite the production of a vaccine for COVID-19 in the UK. Moreover, Stempeutics Research has filed application seeking European Commission Funding to develop cell therapy for COVID 19. The company has also entered into partnership with global consortium of cell therapy companies to gather funding for cell therapy research from European commission. Hence, Europe Cell therapy bioprocessing market is likely to show significant growth prospects during this pandemic and forecasted year.

 


Get more information on this report :



Market Overview and Dynamics

The Cell therapy bioprocessing market in Europe is expected to grow from US$ 3,627.3 million in 2021 to US$ 8,652.1 million by 2028; it is estimated to grow at a CAGR of 13.2% from 2021 to 2028. In June 2018, Celixir plc acquired Desktop Genetics to develop CRISPR-based gene editing. In August 2018, bluebird bio, Inc. and Gritstone Oncology, Inc. have collaborated to develop and commercialize cell therapy products, intended for cancer treatment. Under the agreement, Gritstone Oncology has utilized its proprietary EDGE artificial intelligence platform to analyze specific tumor types. EDGE AI platform has helped in identifying tumor-specific targets and natural T-cell receptors (TCRs) that are used as targets by bluebird bio to develop cell therapies. And further, Gritstone Oncology has utilized those identified targets to conduct development, manufacturing, and commercial processes. Thus, such innovations are expected to foster the cell therapy bioprocessing and enhance the market growth in the coming years.

 

Key Market Segments

In terms of technology, the bioreactors segment accounted for the largest share of the Europe cell therapy bioprocessing market in 2020. In terms of cell type, the stem cell segment accounted for the largest share of the Europe cell therapy bioprocessing market in 2020. In terms of indication, the oncology segment accounted for the largest share of the Europe cell therapy bioprocessing market in 2020. In terms of end user, the academic and research institute segment held a larger market share of the cell therapy bioprocessing market in 2020.

 

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the Cell therapy bioprocessing market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Fresenius Kabi Ag., Asahi Kasei Corporation, Sartorius Ag, Merck Kgaa, Thermo Fisher Scientific Inc., Corning Incorporated, Cytiva (Ge Healthcare), Lonza, Repligen, and Catalent Inc.

 

Reasons to buy report

  • To understand the Europe Cell therapy bioprocessing market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe Cell therapy bioprocessing market
  • Efficiently plan M&A and partnership deals in Europe Cell therapy bioprocessing market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe Cell therapy bioprocessing market
  • Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.

 

EUROPE CELL THERAPY BIOPROCESSING MARKET SEGMENTATION

 

By Technology

  • Bioreactor
  • Lyophilization
  • Electrospinning
  • Control flow Centrifugation
  • Ultrasonic Lysis
  • Genome Editing Technology
  • Cell Immortalization Technology
  • Viral Vector Technology

 

By Cell Type

  • Stem Cell
  • Immune Cell
  • Human Embryonic Stem Cell
  • Pluripotent Stem Cell
  • Hematopoetic Stem Cell

 

By Indication

  • Cardiovascular Disease (CVD)
  • Oncology
  • Wound Healing
  • Orthopedic
  • Others

 

By End User

  • Hospitals and Clinics
  • Diagnostic Centers
  • Regenerative Medicine Centers
  • Academic and Research Institute

 

By Country

  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe

 

Companies Mentioned

  1. Fresenius Kabi Ag.
  2. Asahi Kasei Corporation
  3. Sartorius Ag
  4. Merck Kgaa
  5. Thermo Fisher Scientific Inc.
  6. Corning Incorporated
  7. Cytiva (Ge Healthcare)
  8. Lonza
  9. Repligen
  10. Catalent Inc

 

 

TABLE OF CONTENTS

1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          Cell Therapy Bioprocessing Market – By Technology

1.3.2          Cell Therapy Bioprocessing Market – By Cell Type

1.3.3          Cell Therapy Bioprocessing Market – By Indication

1.3.4          Cell Therapy Bioprocessing Market – By End User

1.3.5          Europe Cell Therapy Bioprocessing Market – By Country

2.           Europe Cell Therapy Bioprocessing Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           Europe Cell Therapy Bioprocessing Market – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          Cell Therapy Bioprocessing Market- Europe PEST Analysis

4.3          Expert Opinion

5.           Europe Cell Therapy Bioprocessing Market - Key Market Dynamics

5.1          Market Drivers

5.1.1          Increasing Investments for Cell and Gene Therapy Manufacturing

5.1.2          Growing Approvals for Cell Therapies

5.2          Market Restraints

5.2.1          Challenges Associated with Cell Therapy Bioprocessing

5.3          Market Opportunities

5.3.1          Automated Procedures to Produce Cell Therapies

5.4          Future Trends

5.4.1          Digital Biomanufacturing

5.5          Impact Analysis

6.           Cell Therapy Bioprocessing Market – Europe Analysis

6.1          Europe Cell Therapy Bioprocessing Market Revenue Forecasts and Analysis

7.           Europe Cell Therapy Bioprocessing Market Analysis and Forecasts To 2028 – By Technology

7.1          Overview

7.2          Cell Therapy Bioprocessing Market Revenue Share, by Technology (2020 and 2028)

7.3          Bioreactor

7.3.1          Overview

7.3.2          Bioreactor: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.4          Lyophilization

7.4.1          Overview

7.4.2          Lyophilization: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.5          Electrospinning

7.5.1          Overview

7.5.2          Electrospinning: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.6          Controlflow Centrifugation

7.6.1          Overview

7.6.2          Controlflow Centrifugation: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.7          Ultrasonic Lysis

7.7.1          Overview

7.7.2          Ultrasonic Lysis: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.8          Genome Editing Technology

7.8.1          Overview

7.8.2          Genome Editing Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.9          Cell Immortalization Technology

7.9.1          Overview

7.9.2          Cell Immortalization Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

7.10        Viral Vector Technology

7.10.1        Overview

7.10.2        Viral Vector Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

8.           Cell Therapy Bioprocessing Market Analysis – By Cell Type

8.1          Overview

8.2          Cell Therapy Bioprocessing Market Revenue Share, by Cell Type (2020 and 2028)

8.3          Stem Cell

8.3.1          Overview

8.3.2          Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

8.4          Immune Cell

8.4.1          Overview

8.4.2          Immune Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

8.5          Human Embryonic Stem Cell

8.5.1          Overview

8.5.2          Human Embryonic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

8.6          Pluripotent Stem Cell

8.6.1          Overview

8.6.2          Pluripotent Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

8.7          Hematopoietic Stem Cell

8.7.1          Overview

8.7.2          Hematopoietic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

9.           Europe Cell Therapy Bioprocessing Market Analysis and Forecasts To 2028 – By Indication

9.1          Overview

9.2          Cell Therapy Bioprocessing Market Revenue Share, by Indication (2020 and 2028)

9.3          Cardiovascular Disease (CVD)

9.3.1          Overview

9.3.2          Cardiovascular Disease (CVD): Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

9.4          Oncology

9.4.1          Overview

9.4.2          Oncology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

9.5          Wound Healing

9.5.1          Overview

9.5.2          Wound Healing: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

9.6          Orthopaedic

9.6.1          Overview

9.6.2          Orthopaedic: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

9.7          Others

9.7.1          Overview

9.7.2          Others: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

10.        Europe Cell Therapy Bioprocessing Market Analysis and Forecasts to 2028– By End User

10.1        Overview

10.2        Cell Therapy Bioprocessing Market Revenue Share, by End User (2020 and 2028)

10.3        Hospitals and Clinics

10.3.1        Overview

10.3.2        Hospitals and Clinics: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

10.4        Diagnostic Centres

10.4.1        Overview

10.4.2        Diagnostic Centres: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

10.5        Regenerative Medicine Centres

10.5.1        Overview

10.5.2        Regenerative Medicine Centres: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

10.6        Academic and Research Institute

10.6.1        Overview

10.6.2        Academic and Research Institute: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

11.        Cell Therapy Bioprocessing Market Revenue and Forecasts to 2028 – Geographical Analysis

11.1        Europe: Cell Therapy Bioprocessing Market Revenue and Forecast to 2028

11.1.1        Overview

11.1.2        Europe: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

11.1.3        Germany: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.1          Germany: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.2          Germany: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.1.3.3          Germany: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.1.3.4          Germany: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.1.3.5          Germany: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.1.4        UK: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.4.1          UK: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.4.2          UK: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.1.4.3          UK: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.1.4.4          UK: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.1.4.5          UK: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.1.5        France: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.5.1          France: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.5.2          France: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.1.5.3          France: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.1.5.4          France: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.1.5.5          France: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.1.6        Spain: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.6.1          Spain: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.6.2          Spain: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.1.6.3          Spain: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.1.6.4          Spain: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.1.6.5          Spain: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.1.7        Italy: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.1          Italy: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.2          Italy: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.1.7.3          Italy: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.1.7.4          Italy: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.1.7.5          Italy: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

11.1.8        Rest of Europe: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.1          Rest of Europe: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.2          Rest of Europe: Cell Therapy Bioprocessing Market, by Technology, 2019–2028 (USD Million)

11.1.8.3          Rest of Europe: Cell Therapy Bioprocessing Market, by Cell Type, 2019–2028 (USD Million)

11.1.8.4          Rest of Europe: Cell Therapy Bioprocessing Market, by Indication, 2019–2028 (USD Million)

11.1.8.5          Rest of Europe: Cell Therapy Bioprocessing Market, by End User, 2019–2028 (USD Million)

12.        Impact Of COVID-19 Pandemic on Europe Cell Therapy Bioprocessing Market

12.1        Europe: Impact Assessment of COVID-19 Pandemic

13.        Industry Landscape

13.1        Overview

13.2        Growth Strategies Done by the Companies in the Market, (%)

13.3        Organic Developments

13.3.1        Overview

13.4        Inorganic Developments

13.4.1        Overview

14.        COMPANY PROFILES

14.1        Fresenius Kabi AG

14.1.1        Key Facts

14.1.2        Business Description

14.1.3        Products and Services

14.1.4        Financial Overview

14.1.5        SWOT Analysis

14.1.6        Key Developments

14.2        Asahi Kasei Corporation

14.2.1        Key Facts

14.2.2        Business Description

14.2.3        Products and Services

14.2.4        Financial Overview

14.2.5        SWOT Analysis

14.2.6        Key Developments

14.3        Sartorius AG

14.3.1        Key Facts

14.3.2        Business Description

14.3.3        Products and Services

14.3.4        Financial Overview

14.3.5        SWOT Analysis

14.3.6        Key Developments

14.4        MERCK KGaA

14.4.1        Key Facts

14.4.2        Business Description

14.4.3        Products and Services

14.4.4        Financial Overview

14.4.5        SWOT Analysis

14.4.6        Key Developments

14.5        THERMO FISHER SCIENTIFIC INC.

14.5.1        Key Facts

14.5.2        Business Description

14.5.3        Products and Services

14.5.4        Financial Overview

14.5.5        SWOT Analysis

14.5.6        Key Developments

14.6        Corning Incorporated

14.6.1        Key Facts

14.6.2        Business Description

14.6.3        Products and Services

14.6.4        Financial Overview

14.6.5        SWOT Analysis

14.6.6        Key Developments

14.7        Cytiva

14.7.1        Key Facts

14.7.2        Business Description

14.7.3        Products and Services

14.7.4        Financial Overview

14.7.5        SWOT Analysis

14.7.6        Key Developments

14.8        Lonza

14.8.1        Key Facts

14.8.2        Business Description

14.8.3        Products and Services

14.8.4        Financial Overview

14.8.5        SWOT Analysis

14.8.6        Key Developments

14.9        Repligen

14.9.1        Key Facts

14.9.2        Business Description

14.9.3        Products and Services

14.9.4        Financial Overview

14.9.5        SWOT Analysis

14.9.6        Key Developments

14.10     Catalent Inc

14.10.1      Key Facts

14.10.2      Business Description

14.10.3      Products and Services

14.10.4      Financial Overview

14.10.5      SWOT Analysis

14.10.6      Key Developments

15.        Appendix

15.1        About the Insight Partners

15.2        Glossary of Terms


LIST OF TABLES

Table 1.              Germany: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 2.              Germany: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 3.              Germany: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 4.              Germany: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5.              UK: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 6.              UK: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 7.              UK: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 8.              UK: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9.              France: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 10.            France: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 11.            France: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 12.            France: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13.            Spain: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 14.            Spain: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 15.            Spain: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 16.            Spain: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17.            Italy: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 18.            Italy: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 19.            Italy: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 20.            Italy: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 21.            Rest of Europe: Cell Therapy Bioprocessing Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 22.            Rest of Europe: Cell Therapy Bioprocessing Market, by Cell Type – Revenue and Forecast to 2028 (USD Million)

Table 23.            Rest of Europe: Cell Therapy Bioprocessing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 24.            Rest of Europe: Cell Therapy Bioprocessing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 25.            Organic Developments Done By Companies

Table 26.            Inorganic Developments Done By Companies

Table 27.            Glossary of Terms, Cell Therapy Bioprocessing Market

 


LIST OF FIGURES

Figure 1.            Cell Therapy Bioprocessing Market Segmentation

Figure 2.            Europe Cell Therapy Bioprocessing Market Overview

Figure 3.            Bioreactor Segment Held Largest Share of Technology in Cell Therapy Bioprocessing Market

Figure 4.            Germany is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.            Cell Therapy Bioprocessing Market - Europe PEST Analysis

Figure 6.            Cell Therapy Bioprocessing Market Impact Analysis of Driver and Restraints

Figure 7.            Europe Cell Therapy Bioprocessing Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8.            Cell Therapy Bioprocessing Market Revenue Share, by Technology (2020 and 2028)

Figure 9.            Bioreactor: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 10.          Lyophilization: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 11.          Electrodspinning: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12.          Controlflow Centrifugation: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13.          Ultrasonic Lysis: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14.          Genome Editing Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15.          Cell Immortalization Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16.          Viral Vector Technology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.          Cell Therapy Bioprocessing Market Revenue Share, by Cell Type (2020 and 2028)

Figure 18.          Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 19.          Immune Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20.          Human Embryonic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21.          Pluripotent Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 22.          Hematopoietic Stem Cell: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 23.          Cell Therapy Bioprocessing Market Revenue Share, by Indication (2020 and 2028)

Figure 24.          Cardiovascular Disease (CVD): Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 25.          Oncology: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 26.          Wound Healing: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 27.          Orthopaedic: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 28.          Others: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 29.          Cell Therapy Bioprocessing Market Revenue Share, by End User (2020 and 2028)

Figure 30.          Hospitals and Clinics: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31.          Diagnostic Centres: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32.          Regenerative Medicine Centres: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33.          Academic and Research Institute: Cell Therapy Bioprocessing Market– Revenue and Forecast to 2028 (US$ Million)

Figure 34.          Europe: Cell Therapy Bioprocessing Market, by Key Country – Revenue (2020) (USD Million)

Figure 35.          Europe: Cell Therapy Bioprocessing Market, by Country, 2020 & 2028 (%)

Figure 36.          Germany: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 37.          UK: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 38.          France: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 39.          Spain: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 40.          Italy: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 41.          Rest of Europe: Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (USD Million)

Figure 42.          Impact of COVID-19 Pandemic in European Country Markets

Figure 43.          Growth Strategies Done by the Companies in the Market, (%)

 

  1. Fresenius Kabi Ag.
  2. Asahi Kasei Corporation
  3. Sartorius Ag
  4. Merck Kgaa
  5. Thermo Fisher Scientific Inc.
  6. Corning Incorporated
  7. Cytiva (Ge Healthcare)
  8. Lonza
  9. Repligen
  10. Catalent Inc
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe cell therapy bioprocessing market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe cell therapy bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the cell therapy bioprocessing market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000